Chinese consumers, once the engine of growth for multinational companies, are cutting back on all kinds of things. Designer ...

like acquiring Acceleron and Prometheus, and cautious, like passing on Seagen due to valuation concerns. BofA Securities writes Merck stock's valuation was too low for an above-average growth profile.

1 Robarts Clinical Trials, Robarts Research Institute, University of Western Ontario, London, Ontario, Canada 2 Department of Medicine, University of Western Ontario, London, Ontario, Canada Objective ...

RAHWAY, N.J., January 28, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly ...

He says, if confirmed, he can still earn referral fees from a firm suing Merck. In 2020, as a pandemic raged across the globe, Robert F. Kennedy Jr. took to social media to appeal to his hundreds ...

Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.56 billion and $1.72 per ...

Robert F. Kennedy Jr. is not qualified to be health and human services secretary for many reasons, chief among them being his years-long unscientific campaign against essential vaccines.

Merck's expansion into cardiovascular treatments and advancements in immunology and inflammation, partly through the Prometheus transaction, are seen as potential growth drivers by analysts.